2-chlorodeoxyadenosine alone and in combination for previously untreated Waldenstrom's macroglobulinemia

Donna M. Weber; Meletios A Dimopoulos; Kay Delasalle; Kim Rankin; Maria Gavino; Raymond Alexanian

doi:10.1053/sonc.2003.50070

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article2002

Extended Rituximab Therapy for Previously Untreated Patients with Waldenström's Macroglobulinemia

Meletios A Dimopoulos, Constantinos Zervas, Athanasios Zomas, George Hamilos, Dimitra Gika, Eleni Efstathiou, Panayiotis Panayiotidis, Elina Vervessou, Nikolaos Anagnostopoulos, John Christakis

Article1993

Treatment of Waldenstrom Macroglobulinemia with 2-Chlorodeoxyadenosine

Meletios A Dimopoulos

Article1994

Primary therapy of Waldenström's macroglobulinemia with 2-chlorodeoxyadenosine.

Meletios A Dimopoulos, H. Kantarjian, D. Weber, S O'brien, E Estey, Kay Delasalle, Esther Rose, Fernando Cabanillas, M Keating, Raymond Alexanian

Article2005

Predictive Factors for Response and Progression after Treatment with Rituximab in Previously Untreated Patients with Waldenstrom’s Macroglobulinemia (WM).

Athanasios K. Anagnostopoulos, Steven P. Treon, Konstantinos Zervas, Andrew R. Branagan, Dimitra Gika, Athanasios Zomas, Marie Christine Kyrtsonis, Amalia Vassou, Nikolaos Anagnostopoulos, Gerasimos Pangalis, Meletios A Dimopoulos

Article1995

Treatment of Waldenstrom's macroglobulinemia resistant to standard therapy with 2-chlorodeoxyadenosine: Identification of prognostic factors

Meletios A Dimopoulos, D. Weber, Kay Delasalle, Michael J. Keating, Raymond Alexanian